Simulated weightlessness induces hippocampal insulin resistance and cognitive impairment

Life Sci. 2023 Nov 15:333:122112. doi: 10.1016/j.lfs.2023.122112. Epub 2023 Sep 25.

Abstract

Growing evidence highlights the potential consequences of long-term spaceflight, including gray matter volume reduction and cognitive dysfunction with subclinical manifestations of diabetes mellitus among astronauts, but the underlying mechanisms remain unknown. In this study, we found that long-term simulated weightlessness induced hippocampal insulin resistance and subsequent neuronal damage and cognitive impairment in rats. Rats subjected to 4-week tail suspension exhibited peripheral insulin resistance, evidenced by increased fasting blood glucose and abnormal glucose tolerance and insulin tolerance, alongside reduced spontaneous activity and impaired recognition memory. In addition, 4 weeks of simulated weightlessness induced neuronal apoptosis and degeneration in the hippocampus, as evidenced by increased TUNEL and Fluoro-Jade B staining-positive neurons. Mechanistically, insulin-stimulated hippocampal Akt phosphorylation was decreased, while PTEN, the negative regulator of insulin signaling, was increased in the hippocampus in tail-suspended rats. Interestingly, treatment with berberine, an insulin sensitizer, partly reversed the above-mentioned effects induced by simulated weightlessness. These data suggest that long-term simulated weightlessness induces cognitive impairment as well as neuronal apoptosis and neural degeneration, partially through hippocampal insulin resistance via PTEN up-regulation. Berberine treatment attenuates hippocampal insulin resistance and improves cognitive function.

Keywords: Berberine; Cognitive impairment; Degeneration; Insulin resistance; Simulated weightlessness; hippocampus.

MeSH terms

  • Animals
  • Berberine*
  • Cognitive Dysfunction* / etiology
  • Hippocampus
  • Insulin
  • Insulin Resistance*
  • Memory Disorders
  • Rats
  • Weightlessness*

Substances

  • Berberine
  • Insulin